SIREN : 451898001
BIOGONE is a French company founded 22 years ago, specialized in the sector Commerce d'alimentation générale. Based in VILLEURBANNE (69100), this company of category PME shows in 2025 a revenue of 3.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 824 381 € | 3 449 791 € | 2 966 263 € | 2 922 701 € | 3 726 986 € | 1 229 579 € | 840 829 € | 812 654 € | 721 105 € |
| Net income | 118 974 € | 88 492 € | 81 212 € | -38 744 € | -27 924 € | 64 789 € | -24 717 € | 20 670 € | 19 047 € |
| EBITDA | 275 327 € | 224 355 € | 170 340 € | 34 451 € | 25 296 € | 75 425 € | -22 339 € | 25 880 € | 23 113 € |
| Net margin | 3.1% | 2.6% | 2.7% | -1.3% | -0.7% | 5.3% | -2.9% | 2.5% | 2.6% |
In 2025, BIOGONE achieves revenue of 3.8 M€. Over the period 2016-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +20.4%. Vs 2024, growth of +11% (3.4 M€ -> 3.8 M€). After deducting consumption (2.6 M€), gross margin stands at 1.2 M€, i.e. a rate of 31%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 275 k€, representing 7.2% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 119 k€, i.e. 3.1% of revenue. This profit can be retained or distributed to shareholders.
3 824 381 €
1 181 782 €
275 327 €
171 395 €
118 974 €
7.2%
The debt ratio (= Financial debt / Equity x 100) stands at 193%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 5.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
193.054%
21.757%
5.819%
2.474
52.6%
In 2025, the debt ratio of BIOGONE (193.05) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2025, the financial autonomy of BIOGONE (21.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2025, the repayment capacity of BIOGONE (2.47) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 155.95. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 7.3x. Operating income very largely covers interest expenses: high safety margin.
155.951
7.328
In 2025, the liquidity ratio of BIOGONE (155.95) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2025, the interest coverage of BIOGONE (7.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 40 days. Excellent situation: suppliers finance 40 days of the operating cycle (retail model). Inventory turnover is 16 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 18 days of revenue, i.e. 187 k€ to permanently finance. Over 2016-2025, WCR increased by +2549%, requiring additional financing.
186 515 €
0 j
40 j
16 j
18 j
Based on 270 transactions of similar company sales in 2025, the value of BIOGONE is estimated at 1 144 710 € (range 521 402€ - 2 006 655€). With an EBITDA of 275 327€, the sector multiple of 4.5x is applied. The price/revenue ratio is 0.33x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 270 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOGONE with other companies in the same sector:
Voir toutes les statistiques du secteur Commerce d'alimentation générale
The revenue of BIOGONE in 2025 is 3.8 M€.
Yes, BIOGONE generated a net profit of 119 k€ in 2025.
The headquarters of BIOGONE is located in VILLEURBANNE (69100), in the department Rhone.
The tax return of BIOGONE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOGONE operates in the sector Commerce d'alimentation générale (NAF code 47.11B). See the 'Sector positioning' section above to compare the company with its competitors.